AG
Adam Goulburn
Founder of Dimension
New York, New York
Overview
Adam Goulburn is the Founder of Dimension, a venture capital firm in New York, with a focus on investing in lifesciences, regenerative medicine, and biotechnology startups. He has a successful track record of founding and leading companies like VNV Bio (now Aera Therapeutics) and Kallyope, along with making strategic investments in companies like Kaleidoscope, Rivet, and Science 37.
With a PhD from Monash University and a background in venture capital at Lux Capital, Adam Goulburn has established himself as a prominent figure in the startup ecosystem, particularly in the health and biotech sectors, through his leadership roles in various successful ventures and investments in innovative companies.
Work Experience
Co-Founder
2022 - Current
Dimension Capital is a venture capital firm that prefers to invest in various industries.
Venture Partner
2022 - 2022
Partner
2015 - 2022
Principal
2014 - 2015
Senior Associate
2012 - 2014
Associate
2011 - 2012
Lux Capital is an investment firm that invests in counter-conventional, seed-stage science and technology ventures.
Founding CEO
2018 - 2021
Founding CEO
2014 - 2015
Kallyope uses the science of gut-brain biology to create medicines that transform human health.
Raised $487,200,000.00 from Bill & Melinda Gates Foundation.
Post-Doctoral Associate
2010 - 2011
Fellow of Neuroscience
Weill Cornell Medicine is an academic medical institution that offers health care services.
Raised $53,500,000.00 from National Cancer Institute, National Institutes of Health, UnitedHealthcare and National Institutes of Health.
Education
PhD
2006 - 2010
Bachelor of Commerce / Bachelor of Science
2001 - 2005